Epidermal growth factor receptor tyrosine kinase - Globe Thesis

Keyword [Epidermal growth factor receptor tyrosine kinase] Result: 81 - 100 \| Page: 5 of 6
81.	Clinical Observation Of Xiao Zhen Tang On EGFR-TKIs Related Rash(Yin Deficiency Type) Of Lung Adenocarcinoma
82.	Study On The Relationship Between The Expression Level Of MiR-221 In Peripheral Blood And The Acquired Resistance Of The First Generation Of EGFR-TKIs In Lung Cancer
83.	The Effect Of Concurrent TP53 Mutations On Clinical Efficacy Of First-generation EGFR-TKIs In Patients With EGFR-mutated Advanced NSCLC
84.	Influence Of TMB And TP53 Gene Mutation On The Efficacy Of Targeted Drugs In Patients With Advanced Lung Cancer Harboring EGFR-sensitive Mutations
85.	The Relationship Between NLR & FIB And Prognosis Of Targeted Treatment In Advanced Lung Adenocarcinoma With EGFR Mutation
86.	The Status Of Targeted Drug Therapy In Lung Cancer And The Mechanism Of Drug Resistance
87.	A Retrospective Analysis Of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs) With Or Without Chemotherapy For Advanced Lung Adenocarcinoma
88.	Experimental Study On EGFR-TKI Resistant Non-Small Cell Lung Cancer With Antiangiogenic Drugs
89.	Effect Of EGFR-TKI Treatment On The Prognosis Of Stage Ⅳ Lung Adenocarcinoma With Chronic Obstructive Pulmonary Disease With High Secretion Of Sputum And Mucus
90.	Study On TCM Syndromes And Correlation Of EGFR-TKIs Targeted Therapy In Patients With Advanced NSCLC
91.	Study On The Role Of MiR-873 In The Reversing Effect Of Intercalated Treatment In Lung Cancer Patients With Acquired Resistance To EGFR Tyrosine Kinase Inhibitors
92.	MiR-206 Involved In Gefitinib Acquired Drug-resistance In Non-small Cell Lung Cancer Patients Through Modulating IL-6 Expression
93.	Study On Pharmacological Effects And Mechanism Of Dihydroartemisinin On Non-small Cell Lung Cancer
94.	Application Value Of EGFR Mutant Protein Expression In Targeted Therapy With Tyrosine Kinase Inhibitors In Advanced Lung Adenocarcinoma
95.	To Investigate The Effect And Mechanism Of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor On The Expression Of IL-6 In EGFR-mutant Lung Cancer Cell Lines
96.	Clinical And Translational Study Of Delayed EGFR-TKI Acquired Resistance By Radiotherapy In Non-small-cell Lung Cancer
97.	Discussion Of Brain Radiotherapy In Patients With EGFR Mutant Lung Adenocarcinoma With Brain Metastasis Treated With EGFR-TKI
98.	Correlation Analysis Of Acquired EGFR T790M Mutation In Advanced Lung Adenocarcinoma
99.	Meta-analysis Of EGFR-TKIs Combined With Anti-vascular Targeting Drugs Versus EGFR-TKIs In The Treatment Of Advanced Non-small Cell Lung Cancer
100.	Detection Of Prognostic Indicators And Survival Analysis In Patients With EGFR Mutant Lung Adenocarcinoma
<<First <Prev Next> Last>> Jump to